Search Results 871-880 of 16400 for monoclonal antibody

1. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

   A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to ...

2. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

   ... monoclonal antibody or hypersensitivity to pembrolizumab or any of its excipients. Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks ...

3. Cryoglobulinemia - Symptoms and causes - Mayo Clinic

   There are three types of cryoglobulinemia. Type 1. This type has one kind of atypical protein, called monoclonal. Type 1 most often is linked to blood cancers.

4. Mayo Clinic Minute: What is CAR-T cell therapy?

   Patients who are newly diagnosed with lymphoma are offered a combination of chemotherapy and antibody-based treatments. But for those who do not respond to ...

5. Curcumin: Can it slow cancer growth? - Mayo Clinic

   Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI · Muscle pain · Needle biopsy · Night sweats · No ...

6. Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

   Has had a prior anti-cancer monoclonal antibody within 4 weeks prior to ... Has a known history of HIV (HIV 1/2 antibodies). Has known active Hepatitis ...

7. A Multicenter Assessment of ALD403 in Chronic Migraine - Mayo Clinic

   Receipt of any monoclonal antibody treatment within 6 months of screening (within or outside a clinical trial); Previously dosed with ALD403 or any ...

8. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

   ... antibody must be negative for HCV RNA by PCR to be eligible for study participation ... Monoclonal and/or bispecific antibodies or CAR T - At least 28 days. 5 ...

9. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   ... monoclonal antibody against LOXL2, in patients with IPF. Read More on PubMed. Additional contact information. Non-cancer trials contact form. Phone: 800-664 ...

10. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients - Mayo Clinic

    Isatuximab is a monoclonal antibody that binds a specific epitope on the human CD38 receptor and has antitumour activity via multiple mechanisms of action.